Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
COMSER is a European CDMO/CMO specializing in product development, lyophilization process design and optimization, contract manufacturing of small molecules and biologics—including antibodies, antibody-drug conjugates, fusion proteins, recombinant proteins—as well as mRNA and protein vaccines. The company focuses on supporting early-stage biopharmaceutical and biotech companies with formulation development through to GMP qualification for clinical trial supply. It does not develop its own therapeutic pipeline but provides essential services enabling client programs to advance into the clinic[2][3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on COMSER.